Certara Services Archives

Case Study

How Model-informed drug development rescue projects from a risky situation

Discover how Certara’s integrated approach to model-informed drug development helps clients navigate regulatory challenges, achieve…

CertaraJune 26, 2025

Publication

Critical Roles for Modeling and Simulation and Real-World Evidence to Inform Challenges in Clinical Trial Diversity Planning

Due to the highly controlled settings of clinical trials, enrolled subjects may not be fully…

Danielle PillsburyJune 19, 2025

Webinar

From Data to Decisions: Real-World Impact of Model-Based Meta-Analysis (MBMA) with GSK and Certara

CertaraJune 18, 2025

Blog

How a budget-impact analysis complements cost-effectiveness to present a balanced economic outlook

June 16, 2025 Editor’s note: This is the third of four articles in our series…

Simona ColucciJune 16, 2025

Announcement

Certara Earns Great Place to Work Certification™ for Fourth Consecutive Year

Certara wins Great Place to Work Certification, with 85% of employees praising workplace culture, innovation,…

CertaraJune 13, 2025

Webinar

Modernizing NCA Workflows: The Power of ADNCA for Regulatory-Ready Pharmacokinetic Analysis

Danielle PillsburyJune 11, 2025

Publication

Assessment of the Effects of Fruquintinib on Cardiac Safety in Patients with Metastatic Colorectal Cancer

The study, published in the Journal of Clinical Pharmacology, evaluates the cardiac safety of fruquintinib,…

CertaraJune 8, 2025

Conference

PSI 2025 Conference

- - Booth

CertaraJune 3, 2025

Webinar

RAPS Sponsored Webcast: Efficient Personalization: Mastering Style Guides and Lexicons for Tailored Submissions

CertaraMay 30, 2025

Press Coverage

What’s next for Trump’s ‘most favored nation’ policy?

The article discusses the latest developments in implementing President Donald Trump’s “most favored nation” policy,…

Danielle PillsburyMay 27, 2025

Certara Services

How Model-informed drug development rescue projects from a risky situation

Critical Roles for Modeling and Simulation and Real-World Evidence to Inform Challenges in Clinical Trial Diversity Planning

From Data to Decisions: Real-World Impact of Model-Based Meta-Analysis (MBMA) with GSK and Certara

How a budget-impact analysis complements cost-effectiveness to present a balanced economic outlook

Certara Earns Great Place to Work Certification™ for Fourth Consecutive Year

Modernizing NCA Workflows: The Power of ADNCA for Regulatory-Ready Pharmacokinetic Analysis

Assessment of the Effects of Fruquintinib on Cardiac Safety in Patients with Metastatic Colorectal Cancer

PSI 2025 Conference

RAPS Sponsored Webcast: Efficient Personalization: Mastering Style Guides and Lexicons for Tailored Submissions

What’s next for Trump’s ‘most favored nation’ policy?

Newsletter sign up

Quick links

Solutions

Contact